/PRNewswire/ Haystack Oncology ("Haystack"), an oncology company that applies the next generation of circulating tumor DNA (ctDNA) detection technology to.
The company was spun out of Johns Hopkins last year to commercialize a circulating tumor DNA-detection technology for minimal residual disease testing.